
WAY Stock Forecast & Price Target
WAY Analyst Ratings
Bulls say
Waystar Holding is a financially sound and innovative company that is poised for continued growth in the healthcare software market. With the recent acquisition of Iodine, the company is expanding its offerings and solidifying its position as a leader in AI-integrated platforms. Waystar's focus on preventing denials and improving revenue is reflected in their strong financial metrics, including a recent increase in total revenue year over year.
Bears say
Waystar Holding is aggressively expanding through acquisition synergies, while also expecting stable Y/Y gross margins and 42% EBITDA margins. Despite a diverse client base, potential reimbursement rate pressures could still impact the company, but Waystar is confident in its competitive displacement and growing traction in the AI healthcare market. Additionally, the company plans to reinvest for long-term growth while maintaining a 40% adjusted EBITDA margin target.
This aggregate rating is based on analysts' research of Waystar Holding Corp and is not a guaranteed prediction by Public.com or investment advice.
WAY Analyst Forecast & Price Prediction
Start investing in WAY
Order type
Buy in
Order amount
Est. shares
0 shares